FDA restores funding to Office of Women’s Health.

Under pressure from women’s health advocates and lawmakers, the Food and Drug Administration has decided to fully fund the agency’s Office of Women’s Health. Last month, reports indicated that the FDA had “quietly removed” one-quarter of this year’s $4 million operating budget. Women’s health advocates believed it was “a long-anticipated payback for the trouble the office stirred during the prolonged debate over nonprescription sales of Plan B.”